Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,142 public trials 2,037 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas

NCT03179930

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Northwestern University (Data Collection Only) Evanston, Illinois, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Active, not recruiting

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

NCT04404283

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • Florida Cancer Specialists Bonita Springs, Florida, United States
View all 143 locations
View Trial Details
Active, not recruiting

A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment

NCT05556798

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, not recruiting

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

NCT06125951

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +18 more
Locations
  • ACW Investigative Site 218 Carlsbad, California, United States
  • ACW Investigative Site 209 Sherman Oaks, California, United States
  • ACW Investigative Site 211 Denver, Colorado, United States
  • ACW Investigative Site 208 Englewood, Colorado, United States
View all 34 locations
View Trial Details
Active, not recruiting

A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia

NCT02251548

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center Coral Gables, Florida, United States
  • University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach, Florida, United States
  • Unversity of Miami Sylvester Comprehensve Cancer Center Miami, Florida, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
View Trial Details
Active, not recruiting

Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

NCT04884035

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Local Institution - 162 Birmingham, Alabama, United States
  • Local Institution - 154 Scottsdale, Arizona, United States
  • Local Institution - 169 Duarte, California, United States
  • Local Institution - 160 Jacksonville, Florida, United States
View all 36 locations
View Trial Details

Related conditions